Companies: 10,795·Total market cap: $144.5T
Rapid Dose Therapeutics Corp.

Rapid Dose Therapeutics Corp.

DOSE.CNCNQHealthcare● Active
$0.09
$-0.01(-5.26%)
Market Cap$11869830
P/E Ratio
52W High$0.24
52W Low$0.085
Overview

Rapid Dose Therapeutics Corp.(DOSE.CN)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · DOSE.CN · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-022024-022023-022022-022021-02
Revenue
Revenue$2.09M$1.02M$0.72M$1.75M$0.76M
Cost of Revenue$0.91M$0.46M$0.35M$0.41M$0.06M
Gross Profit$1.18M$0.56M$0.37M$1.34M$0.70M
Gross Margin %(computed)56.59%55.24%51.85%76.77%92.67%
Operating Expenses
R&D Expenses$0.15M$0.43M$0.09M$0.36M$0.09M
G&A Expenses$4.24M$2.36M$2.95M$4.23M$1.34M
Total Operating Expenses($4.22M)$4.30M$4.18M$5.78M$2.33M
Operating Income$5.40M($3.74M)($3.81M)($4.43M)($1.78M)
Operating Margin %(computed)259.18%-366.57%-530.14%-253.14%-235.30%
Interest Income$0.00M$0.00M$0.00M$0.00M$0.00M
Interest Expense$1.23M$0.66M$0.26M$0.13M$0.14M
Income Before Tax($5.40M)($4.31M)($3.81M)($8.49M)($1.80M)
Income Tax Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Net Income($5.40M)($4.31M)($3.81M)($8.49M)($1.80M)
Net Margin %(computed)-259.18%-422.16%-530.42%-484.42%-239.01%
Per Share & EBITDA
EPS (Basic)$-0.04$-0.04$-0.04$-0.08$-0.02
Wtd Avg Shares124.57M104.96M103.42M100.22M77.79M
EBITDA($3.93M)($3.02M)($2.92M)($7.59M)($0.99M)
EBITDA Margin %(computed)-188.53%-296.57%-406.24%-433.11%-130.69%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · CAD · M

深入了解Rapid Dose Therapeutics Corp.

关于Rapid Dose Therapeutics Corp.(DOSE.CN)损益表

Rapid Dose Therapeutics Corp.(DOSE.CN)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,DOSE.CN实现营收$0.00B,毛利润$0.00B(毛利率56.59%),净利润($0.01B)(净利率-259.18%)。

常见问题

DOSE.CN · 4 问

Rapid Dose Therapeutics Corp.(DOSE.CN)2025财年营收为$0.00B,同比up104.4%。

DOSE.CN revenueDOSE.CN salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09